Wird geladen...
Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials
Although it is common to analyze efficacy and safety separately in clinical trials, this could yield a misleading study conclusion if an increase in efficacy is accompanied by a decrease in safety. A risk-benefit analysis is a systematic approach to examine safety and efficacy jointly. Both the “ran...
Gespeichert in:
| Veröffentlicht in: | Clin Infect Dis |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7319261/ https://ncbi.nlm.nih.gov/pubmed/31414121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz784 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|